BIBLIOMETRIK ANALIZ: CHEK2 GENI VA KO’KRAK BEZI SARATONI
;
CHEK 2 geni, ko’krak bezi saratoni, mutatsiya.Abstrak
Saraton hastaligi butun dunyoda sog'liqni saqlash tashkilotlarining asosiy muammolaridan biri bo’lib kelmoqda. Hayot davomida saraton (75 yoshgacha) rivojlanish xavfi taxminan 20% va saraton kasalligidan o'lish xavfi 10% tashkil qiladi [1]. Har besh kishidan biri hayoti davomida saraton kasalligiga duchor bo'ladi va hastalikga chalingan bemorlarning o'ntasidan bittasi kasallikdan vafot etadi. 2020-yilda saraton bilan kasallanishning 2,26 million yangi holatlar qayt etilgan [2]. Ayollarda ko'krak bezi saratoni dunyo bo'ylab eng ko'p tashxis qo'yiladigan va hastalangan ayollar o’limiga sabab bo’ladigan saraton turi hisoblanadi [3].
Iqtiboslar
Aleksakhina SN, Iyevleva AG, Sokolenko AP, et al. (2021) Loss of heterozygosity in CHEK2-associated breast cancer. Voprosy Onkologii 67: 658–664.
Agaoglu NB, Ng OH, Unal B, et al. (2022) Concurrent Pathogenic Variants of BRCA1, MUTYH and CHEK2 in a Hereditary Cancer Family. Cancer Genetics 268–269: 128–136.
Agiannitopoulos K, Papadopoulou E, Tsaousis GN, et al. (2019) Characterization of the c.793-1G > A splicing variant in CHEK2 gene as pathogenic: A case report. BMC Medical Genetics 20.
Ansari N, Shahrabi S, Khosravi A, et al. (2019) Prognostic Significance of CHEK2 Mutation in Progression of Breast Cancer. Lab Medicine 50: e36–e41.
Acevedo F, Deng Z, Armengol VD, et al. (2018) Managing Patient with Mutations in PALB2, CHEK2, or ATM. Current Breast Cancer Reports 10: 74–82.
Apostolou P, Dellatola V, Papadimitriou C, et al. (2021) Article chek2 pathogenic variants in greek breast cancer patients: Evidence for strong associations with estrogen receptor positivity, overuse of risk-reducing procedures and population founder effects. Cancers 13.
Apostolou P, Fostira F, Mollaki V, et al. (2018) Characterization and prevalence of two novel CHEK2 large deletions in Greek breast cancer patients. Journal of Human Genetics 63: 877–886.
Ansari N, Shahrabi S, Khosravi A, et al. (2019) Prognostic Significance of CHEK2 Mutation in Progression of Breast Cancer. Laboratory Medicine 50: e36–e41.
Global Burden of Disease Cancer Collaboration, Fitzmaurice C, Abate D, et al. (2019) Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncol 5: 1749.
Delwiche FA (2018) Bibliometric Analysis of Scholarly Publications on the Zika Virus, 1952–2016. Science & Technology Libraries 37: 113–129.
Franco P, De Felice F, Jagsi R, et al. (2023) Breast cancer radiation therapy: A bibliometric analysis of the scientific literature. Clinical and Translational Radiation Oncology 39: 100556.
Fresno-Alba S, Denche-Zamorano Á, Pastor-Cisneros R, et al. (2023) Breast cancer and physical activity: A bibliometric analysis. Front Oncol 12: 1051482.
Gu J, Hu M, Chen Y, et al. (2023) Bibliometric analysis of global research on physical activity and sedentary behavior in the context of cancer. Front Oncol 13: 1095852.
